Introduction:Basic information about CAS 53179-07-0|Nisoxetine, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Nisoxetine |
|---|
| CAS Number | 53179-07-0 | Molecular Weight | 271.35400 |
|---|
| Density | 1.054g/cm3 | Boiling Point | 404.8ºC at 760mmHg |
|---|
| Molecular Formula | C17H21NO2 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 170.6ºC |
|---|
Names
| Name | 3-(2-Methoxyphenoxy)-N-methyl-3-phenyl-1-propanamine |
|---|
| Synonym | More Synonyms |
|---|
Nisoxetine BiologicalActivity
| Description | Nisoxetine is a potent and selective inhibitor of noradrenaline transporter (NET), with a Kd of 0.76 nM. Nisoxetine is an antidepressant and local anesthetic, it can block voltage-gated sodium channels[1][2][3]. |
|---|
| Related Catalog | Signaling Pathways >>Membrane Transporter/Ion Channel >>Sodium ChannelResearch Areas >>Neurological DiseaseSignaling Pathways >>Membrane Transporter/Ion Channel >>Monoamine Transporter |
|---|
| Target | Kd: 0.76 nM (NET)[1] |
|---|
| In Vitro | Nisoxetine 抑制 [3H]Nisoxetine 与大鼠额叶皮层膜的结合,Ki 为 1.4±0.1 nM[2]。 Nisoxetine 抑制[3H]去甲肾上腺素摄取到大鼠额叶皮质突触体中,Ki 为 2.1±0.3 nM[2]。 Nisoxetine 抑制 Na+ 电流,膜电位为 -70 和 -100 mV 时的 IC50 分别为 1.6 和 28.6 µM[3]。 |
|---|
| In Vivo | Nisoxetine (2.2 µM; a single intrathecal injection) shows 100, 100, and 100% of blockades in motor function, proprioception, and with duration of action of about 61, 96, and 236 min, respectively[3]. Nisoxetine (3,10, 30 mg/kg, i.p.) inhibits refeeding response (intake of standard chow) in rats[4]. Animal Model: Sprague-Dawley rats(290-340 g)[3] Dosage: 0.6, 1.2, 1.8, 2.2 µM Administration: A single intrathecal injection Result: Showed ED50s of 0.82, 0.75 and 0.70 µM in blocking motor function, proprioception, and nociception respectively. |
|---|
| References | [1]. Béïque JC, et, al. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. Eur J Pharmacol. 1998 May 15; 349(1): 129-32. [2]. Cheetham SC, et, al. [3H]nisoxetine-a radioligand for noradrenaline reuptake sites: correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments. Neuropharmacology. 1996 Jan; 35(1): 63-70. [3]. Leung YM, et, al. Nisoxetine blocks sodium currents and elicits spinal anesthesia in rats. Pharmacol Rep. 2013; 65(2): 350-7. [4]. Bello NT, et al. High-fat diet-induced alterations in the feeding suppression of low-dose nisoxetine, a selective norepinephrine reuptake inhibitor. J Obes. 2013;2013:457047. |
|---|
Chemical & Physical Properties
| Density | 1.054g/cm3 |
|---|
| Boiling Point | 404.8ºC at 760mmHg |
|---|
| Molecular Formula | C17H21NO2 |
|---|
| Molecular Weight | 271.35400 |
|---|
| Flash Point | 170.6ºC |
|---|
| Exact Mass | 271.15700 |
|---|
| PSA | 30.49000 |
|---|
| LogP | 3.81570 |
|---|
| Index of Refraction | 1.547 |
|---|
| InChIKey | ITJNARMNRKSWTA-UHFFFAOYSA-N |
|---|
| SMILES | CNCCC(Oc1ccccc1OC)c1ccccc1 |
|---|
Safety Information
Customs
| HS Code | 2922299090 |
|---|
| Summary | 2922299090. other amino-naphthols and other amino-phenols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|---|
Synonyms
| 3,5-dicarbomethoxy-1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)pyridine |
| Adalat CC |
| 4-(2'-nitro-phenyl)-2,6-dimethyl-3,5-dimethoxycarbonyl-1,4-dihydro-pyridine |
| Procardia XL |
| 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine-dicarboxylic acid dimethyl ester |
| Procardia |
| Adalat |
| [125I]-Iodonisoxetine |
| (R,S)-nisoxetine |
| [3H]-Nifedipine |
| Fenihidin |
| N-methyl-3-(2-methoxyphenoxy)-3-phenylpropylamine |
| Cordipin |
| [3H]-Nisoxetine |
| Fenihidine |
| N-methyl-3-(2-methoxyphenoxy)-3-phenyl-1-propylamine |
| Corinfar |
| 4-(2-nitrophenyl)-3,5-dimethoxycarbonyl-2,6-dimethyl-1,4-dihydropyridine |
| nifedipine |
| 4-(2'-nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridine |